DIURETICS AND ELECTROLYTE DISTURBANCES - PowerPoint PPT Presentation

1 / 23
About This Presentation
Title:

DIURETICS AND ELECTROLYTE DISTURBANCES

Description:

REVIEW TUBULAR TRANSPORT AND DIURETIC MECHANISMS OF ACTION ... REDUCE THE POSI-TIVE TRANSPORT POTENTIAL TO ZERO ... Off' by Reducing the Transport PD to Zero ... – PowerPoint PPT presentation

Number of Views:161
Avg rating:3.0/5.0
Slides: 24
Provided by: davidwa2
Category:

less

Transcript and Presenter's Notes

Title: DIURETICS AND ELECTROLYTE DISTURBANCES


1
DIURETICS AND ELECTRO-LYTE DISTURBANCES
  • DAVID G. WARNOCK, MD
  • UNIVERSITY OF ALABAMA
  • AT BIRMINGHAM

2
DIURETICS AND ELECTROLYTE DISTURBANCES
  • REVIEW TUBULAR TRANSPORT AND DIURETIC MECHANISMS
    OF ACTION
  • REVIEW INDICATIONS AND SIDE EFFECTS OF DIURETIC
    CLASSES
  • DEVELOP AN UNDERSTANDING OF CLINICAL SITUATIONS
    WHERE THE CHOICE OF A SPECIFIC DIURETIC AGENT
    MAKES A DIFFERENCE

3
DIURETICS AND ELECTROLYTE DISTURBANCES
  • PROXIMAL TUBULE - CA INHIBITORS
  • THICK ASCENDING LIMB -
  • LOOP AGENTS
  • DISTAL CONVOLUTED TUBULE -
  • THIAZIDE DIURETICS
  • COLLECTING TUBULE -
  • K SPARING DIURETICS
  • OSMOTIC DIURETICS

4
DIURETICS AND ELECTROLYTE DISTURBANCES
  • DIURETIC-INDUCED RENAL K WASTING
  • Increased Distal Na Delivery Drives K Secretion
  • High Renin and Aldo
  • H Secretion is Also Enhanced
  • Associated Metabolic Alkalosis

5
PROXIMAL TUBULE CARBONIC ANHYDRASE INHIBITORS
  • SITE OF ACTION
  • INHIBITS HCO3 REABSORPTION IN PROXIMAL TUBULE
  • BICARBONATURIA RESULTS FROM ??CA ACTIVITY IN BBM
  • SHORT TERM ??IN URINE pH

6
PROXIMAL TUBULE CARBONIC ANHYDRASE INHIBITORS
  • INDICATIONS
  • GLAUCOMA, URINE ALKALINIZATION, MOUNTAIN SICKNESS
  • TOXICITIES
  • HYPERCHLOREMIC METABOLIC ACIDOSIS
  • CaPO4 STONES
  • RENAL K WASTING
  • NH3 INTOXICATION

7
THICK ASCENDING LIMB
  • LOOP AGENTS INHIBIT Na, K, 2Cl- CO-TRANSPORTER
    AT THE LUMEN SIDE
  • REDUCE THE POSI-TIVE TRANSPORT POTENTIAL TO ZERO
  • INCREASE URINARY NaCl and K, Mg2 AND Ca2
    EXCRETION

8
THICK ASCENDING LIMB
  • INDICATIONS FOR LOOP AGENTS
  • Pulmonary Edema
  • Refractory Edema
  • Hypercalcemia
  • TOXICITIES
  • K and Mg2 Wasting
  • Metabolic Alkalosis
  • Hypercalciuria
  • Ototoxicity

9
DISTAL CONVOLUTED TUBULE
  • THIAZIDES INHIBIT THE LUMINAL NaCl COTRANSPORTER
  • REDUCE THE NEGA-TIVE TRANSPORT POTENTIAL TO 0 mV
  • INCREASE URINARY NaCl and K, BUT NOT Ca2
    EXCRETION

10
DISTAL CONVOLUTED TUBULE THIAZIDES
  • Ca2 ABSORPTION IS ENHANCED
  • Negative Transepithelial Potential Retards Ca2
    Absorption
  • Thiazides Take the Brake Off by Reducing the
    Transport PD to Zero
  • Alternatively, Hyperpolarization of Membrane PD
    May Activate Ca2 Entry
  • Thiazide Effect on Ca2 Absorption is Blunted by
    Excess Dietary NaCl

11
DISTAL CONVOLUTED TUBULE
  • INDICATIONS FOR THIAZIDES
  • HTN and CHF
  • Hypercalciuria
  • TOXICITIES
  • Renal K Wasting
  • Metabolic Alkalosis
  • Increased Lipids, Uric Acid and Glucose

12
COMBINED USE OF AGENTS
  • THIAZIDES AND LOOP AGENTS HAVE DISTINCT SITES AND
    MECHANISMS OF ACTION
  • TRUE SYNERGIC EFFECT OCCURS
  • UNMASKING OF A PROXIMAL EFFECT
  • ADAPTATION OF DISTAL CONVOLUTED TUBULE TO CHRONIC
    INHIBITION OF THICK ASCENDING LIMB FUNCTION

13
COMBINED USE OF AGENTS
  • INDICATIONS FOR COMBINED THERAPY
  • REFRACTORY EDEMA
  • SEVERE HYPERKALEMIA
  • TOXICITIES
  • RENAL K WASTING
  • METABOLIC ALKALOSIS

14
DIURETICS AND ELECTROLYTE DISTURBANCES
  • DIURETIC-INDUCED RENAL K WASTING
  • Increased Distal Na Delivery Drives K Secretion
  • High Renin and Aldo
  • H Secretion is Also Enhanced
  • Associated Metabolic Alkalosis

15
COLLECTING TUBULE
  • SITE OF FINAL REGULATION OF SALT, WATER AND
    ACID-BASE BALANCE
  • MULTITUDE OF HORMONAL CONTROL MECHANISMS
  • 3 SPECIFIC FUNCTIONAL ASPECTS
  • Na and K Transport
  • Water Transport
  • H Transport

16
COLLECTING TUBULE
  • K SPARING AGENTS INHIBIT LUMINAL Na CHANNEL
    ACTIVITY
  • REDUCE THE NEGA-TIVE TRANSPORT PD TO ZERO
  • INCREASE URINARY NaCl EXCRETION

17
COLLECTING TUBULE
  • INDICATIONS FOR K SPARING AGENTS
  • Primary and Secon-dary Aldosteronism
  • TOXICITIES
  • Hyperkalemia
  • Metabolic Acidosis
  • BPH, Gynecomastia with Spironolactone
  • ARF, Stones

18
DIURETIC INDUCED K WASTING
  • REDUCE DIURETIC DOSING TO ? ALDO
  • REDUCE DIETARY NaCl INTAKE
  • K SUPPLEMENTS
  • ADD K SPARING DIURETICS IN CON- JUNCTION WITH
    SALT RESTRICTION

19
COLLECTING TUBULEADH RESPONSE
  • HYDRO-OSMOTIC RESPONSE TO ADH CONCENTRATES THE
    URINE
  • AQP-3 Expressed in the Baso-Lateral Membrane
  • ADH causes insertion of AQP-2 into the apical
    membrane

20
COLLECTING TUBULE OSMOTIC DIURETICS
  • OSMOTIC H2O FLOW IS DRIVEN BY MEDUL-LARY
    HYPERTONICITY
  • OSMOTIC DIURETICS OBLIGATE FREE WATER EXCRETION
  • MAJOR EFFECT IN H2O PERMEABLE SEGMENTS

21
COLLECTING TUBULE OSMOTIC DIURETICS
  • INDICATIONS FOR OSMOTIC AGENTS
  • REDUCTION OF INTRACELLULAR VOLUME (eg. CEREBRAL
    EDEMA)
  • INTRA-TUBULAR OBSTRUCTION (CAST NEPHROPATHY,
    RHABDOMYOLYSIS)
  • TOXICITIES
  • HYPERNATREMIA
  • VOLUME DEPLETION
  • ACUTE RENAL FAILURE

22
DIURETICS AND ELECTROLYTE DISTURBANCES
  • REVIEW TUBULAR TRANSPORT AND DIURETIC MECHANISMS
    OF ACTION
  • Specificity of Diuretic Effects Are a Reflection
    of Their Sites of Action
  • Tubular Transport Mechanisms Have Been Recently
    Illuminated By Studies of the Effects of Specific
    Diuretic Agents
  • Linear Heterogeneity and Integrative Function
    Explain Global Effects

23
DIURETICS AND ELECTROLYTE DISTURBANCES
  • REVIEW INDICATIONS AND SIDE EFFECTS OF DIURETIC
    CLASSES
  • Side Effects Are in Large Part Dose-Dependent and
    Predictable From the Known Effects of Each
    Diuretic Class
  • Specific Indications Are Predicated On the
    Effects of Each Class of Agents
  • Combination Agents Can Be Rational Therapeutic
    Choices
Write a Comment
User Comments (0)
About PowerShow.com